Association of Chairs of Departments of Physiology · Association of Chairs of Departments of...

Association of Chairs of Departments of Physiology 9650 Rockville Pike, Suite E314 Bethesda, Maryland 20814-3991 Tel. 301-634-7785; Fax: 301-634-7098 November 24, 2010 Dear Attendees: As President of ACDP for 2010, I would like to take this opportunity to thank you for attending our annual ACDP Retreat on December 2-5, 2010 in Bonita Springs, FL, at the Hyatt Regency Coconut Point Resort and Spa, www.coconutpoint.hyatt.com. The resort offers several half-day and full-day excursions to area attractions, such as Everglades National Park, fishing tours, Edison/Ford Winter Estates and an eco tour. There is also golf and shopping nearby. This year, our meeting will begin with a presentation from Kevin Grigsby, Senior Director, Organizational Leadership Development, Association of American Medical Colleges. He will cover the issues of the changing landscape for the basic science departments, the un-sustainability of the current financial model for funding academic medical centers, developing an orientation toward the future rather than toward the past, why it is an imperative to recruit and retain top talent, and how NOT to fail as a leader in academic medicine and science. Additionally, Kevin has agreed to provide a presentation on his research interest, kaolin-specific pica (http://www.georgiaencyclopedia.org/nge/Article.jsp?id=h-2669&sug=y). In response to growing concerns about departmental mergers of academic disciplines and how to handle these procedures, I have asked JR Haywood from Michigan State University to provide insight into how to squeeze intellect into an administrative model that works for merging departments. Barbara Sanborn, Colorado State University and Tom Westfall, Saint Louis University will add to the discussion of this important issue. On Saturday, the Fourth Guyton Lecture will be presented by Ferid Murad, University of Texas Health Sciences Center, Houston. As many of you know, he is the co-winner of the 1998 Nobel Prize in Physiology or Medicine. Other highlights of the meeting include our new chair presentation by Nader Abraham, University of Toledo and a scientific review of retinal physiology by Frank Werblin, University of California, Berkeley. Mary Woolley, Research!America will tell us about important advocacy issues. John Williams, University of Michigan will be presented with the Distinguished Service Award at our Saturday banquet. I look forward to spending time with you in Bonita Springs! Sincerely,

R. Clinton Webb, Ph.D. President Officers 2009-2010 R. Clinton Webb, President Gary Sieck, President-elect Meredith Bond, Past-President Chris Cheeseman, Sec/Treasurer

Councilors Nicholas A. Delamere (2011) Steven R. Houser (2010) Patricia E. Molina (2012) Marshall H. Montrose (2011) T. Richard Nichols (2011) Michael B. Reid (2012)

CAS Representatives L. Gabriel Navar (2011) William Spielman (2011)

ACDP Meeting December 2-5, 2010 Hyatt Regency Coconut Point, Bonita Springs, Florida

~ Program ~

Thursday, December 2, 2010

1:00 – 5:00 p.m. Registration 4:00 – 5:00 p.m. Executive Council Meeting I (Webb Presidential Suite) 5:30 – 6:00 p.m. Executive Council Meeting II (Webb Presidential Suite) 6:30 – 8:00 p.m. Welcome Reception (Waterfall Pool Deck) (Weather Backup - Estero A)

Friday, December 3, 2010

7:00 – 7:30 a.m. Registration 7:00 – 8:00 a.m. Continental Breakfast (Estero Terrace) 8:00 a.m. – 4:45 p.m. Meeting (Estero C) SESSION CHAIR: Clinton Webb, Ph.D., President 8:00 – 8:30 a.m. Welcome and introduction of new chairs SESSION CHAIR: Steven Houser 8:30 – 10:30 a.m. R. Kevin Grigsby, D.S.W., Senior Director, Organizational Leadership

Development, Association of American Medical Colleges “A strategy for departmental innovation: driving toward sustainable growth.” (presentation, break-out groups, scenarios).

10:30 – 11:00 a.m. Coffee Break (Estero Terrace) 11:00 – noon R. Kevin Grigsby, D.S.W., Senior Director, Organizational Leadership Development,

Association of American Medical Colleges “A strategy for departmental innovation: recruiting and retaining the top talent.”

12:00 – 1:00 p.m. Lunch (Estero Terrace) SESSION CHAIRS: Paul Cheney and Donna Korzick 1:00 – 2:00 p.m. JR Haywood, Ph.D., Departments of Physiology and Pharmacology and Toxicology,

Michigan State University, “A chaotic experience of merging intellect and administration.” Discussion: Barbara Sanborn, Ph.D., Colorado State University and Thomas Westfall, Ph.D.,

St. Louis University 2:00 – 2:30 p.m. R. Kevin Grigsby, D.S.W., AAMC, “Kaolin-specific pica.”

ACDP Meeting December 2-5, 2010; Hyatt Regency Coconut Point, Bonita Springs, FL 2:30 – 3:15 p.m. Mary Woolley, President, Research!America, “World Class Advocacy for World Class

Research.” 3:15 – 4:00 p.m. Bishr Omary, Ph.D., Department of Molecular and Integrative Physiology, University

of Michigan, “A proposal to increase the use of R56 awards by the National Institutes of Health (http://grants.nih.gov/grants/funding/r56.htm).”

4:00 – 4:45 p.m. Business Meeting I:

Call for nominations of officers; CAS Report; Treasurer’s Report National Directors of Graduate Studies, funding request from William F. Jackson ($1,500), July 7-9, 2011, Michigan State University.

Dinner on your own

Saturday, December 4, 2010

7:00 – 8:00 a.m. Continental Breakfast (Estero Terrace) 8:00 a.m. – 3:00 p.m. Meeting (Estero C) SESSION CHAIRS: Gabriel Navar and Meredith Bond 8:15 – 9:15 a.m. Ferid Murad, M.D., Ph.D., Brown Foundation Institute of Molecular Medicine for the

Prevention of Human Diseases, University of Texas Health Science Center, Houston, Fourth Guyton Lecturer: “Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development.”

9:30 – 10:15 a.m. New Chair presentation: Nader Abraham, Ph.D., Dr.H.C, F.A.H.A., Department of

Physiology and Pharmacology, University of Toledo, “Antioxidants and stem cell therapy: Sources, cell types and clinical applications.”

10:15 – 10:30 a.m. Coffee Break (Estero Terrace) 10:30 a.m. – 12:00 p.m. L. Gabriel Navar, Ph.D., Department of Physiology, Tulane University,

“Medical school teaching objectives” 12:00 – 1:00 p.m. Lunch (Estero Terrace) SESSION CHAIRS: Nicholas Delamere and Marlene Wilson 1:00 – 2:00 p.m. Frank Werblin, Ph.D., University of California, Berkley, “The retina simplified.” 2:00 – 2:30 p.m. Martin Frank. Ph.D., Executive Director, American Physiological Society, “APS

Update & APS Chapter Advisory Committee.” 2:30 – 3:00 p.m. Business Meeting II (Election of 2011 Officers; Plans for 2011 Meeting…..) 3:00 – 5:30 p.m. Free time

ACDP Meeting December 2-5, 2010; Hyatt Regency Coconut Point, Bonita Springs, FL 5:30 - 6:30 p.m. Gala Cocktail Hour (Estero Terrace) 6:30 – 10:00 p.m. Dinner Banquet (Estero A)

Announcement of 2011 Officers. Distinguished Service Award to: John A. Williams, M.D., Ph.D., University of Michigan.

Sunday, December 5, 2010

7:00 - 8:00 a.m. Continental Breakfast (Great Egret BC)

Informal discussion and meeting recap. Meeting adjourns

(12/10/09) ACDP 2009-2010 Officers

President (Term ends 2010) R. Clinton Webb, Ph.D. Dept. of Physiology Medical College of Georgia 1120 15th St. Augusta, GA 30912-3000 Tel: 706-721-2781 Fax: 706-721-7299 Email: [email protected] Past President (Term ends 2010) Meredith Bond, Ph.D. Department of Physiology, BRB-5007 University of Maryland School of Medicine 655 West Baltimore St., 5th Floor Baltimore, MD 21201-1559 Tel: 410-706-1922 Fax: 410-706-8341 Email: [email protected] Councilor (Term ends 2011) Nicholas A. Delamere, Ph.D. Department of Physiology Univ. of Arizona 1501 N. Campbell Ave. Tucson, AZ 85724 Phone: 520-626-6425 Fax: 520-626-2382 Email: [email protected] Councilor (Term ends 2012) Patricia E. Molina, M.D., Ph.D. Department of Physiology Louisiana State Univ. Hlth Sci Center 1901 Perdido Street New Orleans, LA 70112-1393 Phone: 504-568-6171 Fax: 504-568-6158 Email: [email protected]

President-elect (Term ends 2010) Gary C. Sieck, Ph.D. Dept. of Physiology and Biomedical Engin. Mayo Clinic College of Medicine 200 First Street S.W., Joseph Rm. 4-184W Rochester, MN 55905 Tel: 507-255-4373 Fax: 507-284-0521 Email: [email protected] Secretary-Treasurer (Term ends 2010) Chris Cheeseman, Ph.D. Department of Physiology University of Alberta 7-22 Med. Sci. Bldg. Edmonton, Alberta T6G 2H7, Canada Tel: 780-492-2620 Fax: 780-492-8915 Email: [email protected] Councilor (Term ends 2010) Steven R. Houser, Ph.D. Department of Physiology Temple University School of Medicine 3400 N. Broad St. Philadelphia, PA 19140 Tel: 215-707-3278 Fax: 215-707-3965 Email: [email protected] Councilor (Term ends 2011) Marshall H. Montrose, Ph.D. Dept. of Molecular & Cellular Physiology Univ. of Cincinnati College of Medicine 231 Albert Sabin Way, MSB 4207 Cincinnati, OH 45267-0576 Phone: 513-558-5636 Fax: 513-558-5738 Email: [email protected]

ACDP Officers (Cont’d) Councilor (Term ends 2010) T. Richard Nichols, Ph.D. School of Applied Physiology Georgia Institute of Technology 281 Ferst Drive Atlanta, GA 30332-0356 Phone: 404-894-3986 Fax: 404-894-9982 Email: [email protected] CAS Representative (Term ends 2010) William S. Spielman, Ph.D. Department of Physiology Michigan State University 2201 Biomedical Physical Sciences East Lansing, MI 48824-3320 Tel: 517-353-4539 Fax: 517-432-1967 Email: [email protected] Executive Assistant Melinda E. Lowy 9650 Rockville Pike, Suite E314 Bethesda, MD 20814-3991 Tel: 301-634-7785 Fax: 301-634-7098 Email: [email protected]

Councilor (Term ends 2012) Michael B. Reid, Ph.D. Department of Physiology Univ. of Kentucky College of Medicine 800 Rose Street, MS-509 Medical Center Lexington, KY 40536-0298 Phone: 859-323-6045 Fax: 859-323-1070 Email: [email protected] CAS Representative (Term ends 2011) L. Gabriel Navar, Ph.D. Department of Physiology Tulane University School of Medicine Box SL39 1430 Tulane Ave. New Orleans, LA 70112 Tel: 504-588-5251 Fax: 504-584-2675 Email: [email protected]

Past Officers of ACDP Presidents (3-yr term: President-elect, President, Past President) 2009-10 R. Clinton Webb Medical College of Georgia 2008-09 Meredith Bond University of Maryland, Baltimore 2007-08 Nicola C. Partridge UMDNJ-RW Johnson Medical School 2006-07 William S. Spielman Michigan State University 2005-06 Richard N. Bergman University of Southern California 2003-05 Peter M. Cala University of California, Davis 2002-03 Irving H. Zucker University of Nebraska 2001-02 Irving G. Joshua University of Louisville 2001 Phyllis M. Wise (resigned as President-elect, took position as Dean) 2000-01 Donald M. Bers Loyola University 1999-2000 William H. Dantzler University of Arizona 1998-99 R. John Solaro University of Illinois at Chicago 1997-98 Mordecai P. Blaustein University of Maryland 1996-97 Paul De Weer University of Pennsylvania 1995-96 L. Gabriel Navar Tulane University 1994-95 Robert D. Foreman University of Oklahoma 1994-95 Antonio Scarpa Case Western Reserve University 1993-94 Wayne E. Crill University of Washington 1992-93 Harel Weinstein Mount Sinai School of Medicine 1991-92 Donald J. Marsh Brown University 1990-91 Allen W. Cowley, Jr. Medical College of Wisconsin 1989-90 Robert B. Gunn Emory University 1988-89 Donald T. Frazier University of Kentucky 1987-88 M. Ian Phillips 1986-87 Stephen H. White 1985-86 Stanley G. Schultz 1984-85 George A. Hedge (replaced Stephen White who was unable to serve as President) 1983-84 Edward J. Masoro 1982-83 F. Norman Briggs 1981-82 Franklyn G. Knox 1980-81 Paul C. Johnson 1979-80 Jack L. Kostyo 1978-79 Leonard Share 1977-78 Charles R. Park 1976-77 W. F. Ganong 1975-76 Howard E. Morgan 1974-75 Norman R. Alpert (replaced James O. Davis who resigned as President-elect) 1973-74 James B. Preston 1972-73 E. B. Brown, Jr. 1971-72 Ewald E. Selkurt 1970-71 Robert M. Berne 1969-70 Ernst Knobil

Councillors (6 Councillors total – 3-yr term; 2 rotate off each year) Patricia E. Molina (2009-12) Michael B. Reid (2009-12) Nicholas A. Delamere (2008-11) Marshall H. Montrose (2008-11) T. Richard Nichols (2008-10) Steven R. Houser (2007-10) Gary Sieck (2007-10) Raymond A. Frizzell (2006-09) Muthu Periasamy (2006-09) Susan L. Hamilton (2005-08) R. Clinton Webb (2005-08) Kenneth D. Philipson (2004-07) Michael L. Jennings (2004-07) Meredith Bond (2004-05) new Councillor position William S. Spielman (2003-06) Joseph C. Dunbar (2003-06) D. Neil Granger (2002-05) Nicola C. Partridge (2002-03) Finishing Peter Cala’s term David C. Dawson (2002-04) Peter M. Cala (2001-02) elected to President-elect Michael Jennings (2001-03) new Councillor position Nicola Partridge (2001-03) finishing Irving Zucker’s term Richard Bergman (2001-02) finishing Irving Joshua’s term Irving Zucker (2000-03) elected to President-elect Irving G. Joshua (1999-2002) elected to President in place of Phyllis Wise Robert E. Fellows (1999-2001) finishing Donald Bers’ term Donald Bers (1998-99) elected to President-elect Irving G. Joshua (1998-99) finishing William Dantzler’s term Phyllis M. Wise (1997-2000) elected to President-elect Donald Bers (1997-98) finishing Aubrey Taylor’s term William H. Dantzler (1996-98) elected to President-elect Aubrey E. Taylor (1995-97) elected to Secretary-Treasurer Kent Sanders (1994-97) Sandra Sabatini (1994-95) finishing Gabby Navar’s term James G. Townsel (1993-96) Paul De Weer (1993-94) finishing Antonio Scarpa’s term L. Gabriel Navar (1992-94) elected to President-elect Antonio Scarpa (1991-93) elected to President-elect James G. Townsel (1992-93) finishing Robert Foreman/Wayne E. Crill’s term Wayne E. Crill (1991-92) finishing Robert Foreman’s term elected to President-elect Robert D. Foreman (1990-91) elected to Secretary-Treasurer Harel Weinstein (1989-91) elected to President-elect Robert Thurber (1988-91)

Benjamin Kaminer (1988-89) finishing Robert Gunn’s term Donald J. Marsh (1987-90) Robert B. Gunn (1986-88) elected to President-elect John J. Spitzer (1985-88) Allen W. Cowley, Jr. (1985-87) finishing Donald Frazier’s term Donald T. Frazier (1984-85) elected to Secretary-Treasurer M. Ian Phillips (1983-86) Allen W. Cowley, Jr. (1984-85) finishing Stanley Schultz’s term Stanley G. Schultz (1982-84) elected to President-elect Jimmy Neill (1981-84) Stephen White (1982-83) finishing Edward Masoro’s term Edward J. Masoro (1980-82) elected to President-elect Joseph P. Gilmore (1979-82) Paul Horowicz (1978-81) William Van der Kloot (1977-80) Paul C. Johnson (1976-79) Jack L. Kostyo (1975-78) Francis Ganong (1974-75) finishing Harry Patton’s term Harold Hempling (1974-77) Charles R. Park (1973-76) elected to President-elect Harry D. Patton (1972-74) Norman R. Alpert (1973-74) finishing James Davis’ term James Davis (1971-73) elected to President-elect Gerhard Giebisch (1970-73) James B. Preston (1969-72) Howard Morgan (1968-71) Secretary-Treasurers (3-year term; renewable) 2007-2010 Chris Cheeseman 2004-2007 Richard L. Moss 2002-2004 Philip M. Best 1997-2001 Aubrey E. Taylor 1994-1997 R. John Solaro elected to President-elect 1991-1994 Robert D. Foreman 1989-1991 Douglas G. Stuart 1988-1989 Allen W. Cowley, Jr. elected to President-elect 1985-1987 Donald T. Frazier (replacing Lowell Stone who deceased) 1984 H. Lowell Stone 1981-1984 George A. Hedge 1980-1981 F. Norman Briggs 1976-1980 Franklyn G. Knox 1974-1976 Leonard Share 1971-1974 Howard E. Morgan elected to President-elect

1970-1971 E. B. Brown, Jr. CAS (2 reps; 3-yr terms, renewable) William S. Spielman (2007-2010) Meredith Bond (2006-2007) Elected President-elect L. Gabriel Navar (1997-2008) Antonio Scarpa (1995-2005) finishing Allen Cowley’s term M. Ian Phillips (1991-97) Allen W. Cowley, Jr. (1992-95) finishing Donald Frazier’s term plus additional term Donald Frazier (1989-92) Stanley G. Schultz (1988-89) finishing Leonard Share’s term Mordecai P. Blaustein (1987-91) Leonard Share (1985-1987) Howard Morgan (1982-85) William F. Ganong (1980-87) Stephen H. White (1980-82) H. Maurice Goodman (1980-81) Daniel Tosteson (1970, 71) Public Affairs Mordecai P. Blaustein (1994-96) Leonard S. Jefferson (1993-94) Charles D. Barnes (1989-1993) Norman R. Alpert (1981-89)

Association of Chairs of Departments of Physiology December 3 – 6, 2009

ACDP Executive Council

Minutes

Present:, Meredith Bond, President; R. Clinton Webb, President-Elect; Nicola C. Partridge, Past President; Chris Cheeseman, Secretary-Treasurer; Nicholas Delamere, Marshall Montrose, Muthu Periasamy, Gary Sieck, Councilors; L. Gabriel Navar, CAS Representative Absent: Raymond Frizzell, Steven R. Houser, Councilors; William Spielman, CAS Representative

I. Approval of Executive Council 2009 Minutes II. Guyton Award Lecture Selection Process

a. Councilors to assist b. Suggestions for 2010

III. Elections a. Nominees for President b. Nominees for Secretary-Treasurer c. Nominees for Councilor d. Nominees for CAS Representative

IV. ACDP Budget V. Newsletters VI. 2010 Annual Meeting

The President, Meredith Bond, called the meeting to order at 4:00 pm and welcomed the members of the Executive Council to Tucson. I. Approval of 2008 Executive Council Minutes Council unanimously approved the 2008 minutes of the Executive Council meeting as written. II. Guyton Award Lecture Selection Process Bond reminded Council that there is a process in place for selecting the Guyton Award Lecturer. Nominations are first solicited from the entire ACDP membership. A subcommittee of the Executive Council, composed of the two new second-year Councilors and the new President, work as a selection committee. The final choice is sent to the full Executive Council for approval. For 2010, Montrose and Delamere will assist Webb in selecting the Lecturer. Navar suggested that Webb contact the publishing company of the Guyton textbook to see if they would consider sponsoring the Lectureship. Partridge noted that last year she contacted John Hall, the co-author of the textbook, who said he thought it would be difficult to get any sponsorship from the company. Webb agreed he would contact the company to see if they were interested. Bond recommended that Webb immediately start to identify possible candidates for the award, as many of the more well-known people have full schedules and are difficult to get less than a year

in advance. Webb noted that he will begin soliciting nominations, with the goal of naming the 2010 Lecturer by March 1, 2010. III. Elections Council discussed various members for the offices of President-elect and Councilor (2 positions). Bond will check with those people about their willingness to serve, as well as invite nominations from meeting attendees. Cheeseman reminded the Council that his term will end in 2010. He recommended that everyone begin thinking about someone who could replace him next year. III. ACDP Budget Cheeseman reviewed the 2009 budget with Council. He noted that the Society is in good financial shape with over $21,000 more than at this time last year. He pointed out the increase was because ACDP collected registration fees this year whereas the travel agent did that last year. Final totals for the year will be less because meeting expenses still have to be finalized. He will present the budget to the membership during the Business Meeting. IV. Newsletters Navar reminded Council that they had voted to have a newsletter for the membership. It was agreed that the Secretary-Treasurer would write and distribute the newsletter. Cheeseman apologized for not getting any sent out over the past year. His new position took a great deal more time than he had expected. He will begin sending them on a quarterly basis, starting with a report on this meeting. Newsletters will contain updates, such as CAS reports, Medical Physiology Objective updates, reports from NIH, joint ACDP/APS initiatives, updates on changes to the LCME, etc. In addition, they will also include notices of new chairs. V. 2010 Annual Meeting President-elect Webb announced that he selected Hyatt Regency Coconut Point Resort and Spa in Bonita Springs, FL for the 2010 ACDP meeting. He will make a presentation during the Business Meeting. He requested input from Council regarding the program for the meeting. The meeting adjourned at 5:35 pm.

ACDP Business Meeting I Minutes

I. Call to Order The Business Meeting was convened by President Meredith Bond at 2:40 pm on December 4, 2009. II. Approval of 2008 Draft Meeting Minutes The minutes from the 2008 Business Meetings were unanimously approved as submitted. III. Announcement of 2009 Guyton Award Lectureship Bond announced that the 3rd Arthur Guyton Lectureship will be given by Helen Hobbs, M.D., Ph.D. from University of Texas Southwestern Medical Center at Dallas. The lecture is titled “MicroRNA Control of Heart Development and Disease.’ IV. Announcement of 2009 Distinguished Service Awardee Bond also announced that Phyllis M. Wise, Ph.D., Provost & Executive Vice President at the University of Washington, will be presented with the 2009 ACDP Distinguished Service Award at the banquet. Wise will be honored for her service as the first female President-elect, as a past Councilor of ACDP, a past Councillor for APS and distinguished physiologist. V. Call for Nominations for Officer Positions A call was made for nominations for President-elect and the two open Councilor positions. VI. Financial Report The financial report was presented by Secretary-Treasurer Chris Cheeseman. The Association remains in sound financial condition and will carry forward a positive balance into 2010 because 2008 meeting costs remained down. Although the numbers look very positive now with a $21,000 excess from this time last year, meeting expenses have yet to be paid. A final 2009 budget will be presented at the 2010 ACDP meeting held during the Experimental Biology meeting. The financial report was accepted unanimously by the attendees. VII. Medical Physiology Learning Objectives Navar reminded the chairs that the Medical Physiology Learning Objectives continually need to be reviewed and updated to keep them current. In addition, Pathophysiology objectives need to be added to each section. Sign-up lists were available for attendees to volunteer to assist in the project and breakout sessions were held Saturday morning. Groups were established for each section of the objectives except for respiration. VIII. CAS Updates Navar described the roles of the two ACDP CAS representatives (Navar and Spielman) and the governance of the AAMC. Navar is currently serving a second term on the CAS Board. The AAMC By-laws and governance structure were reviewed last year and no changes were recommended.

Other topics of interest to AAMC and CAS are changes in the USMLE, medical schools and their programs, background checks on incoming students, and current legislative items. In addition, CAS also is interested in the physician work force, curriculum changes, and interacting with osteopathic schools. CAS did raise the issue of having another National Basic Sciences meeting. The last one was held in 2005. Initially another one was tentatively scheduled for 2010, but with the economy woes, it has been delayed for a future, unspecified date. The next CAS meeting is scheduled for March 4 in Austin, TX. Topics under consideration will include identifying evolving issues in medical school teaching, health care reform, faculty leadership development, and the recruitment and retention of faculty.

ACDP Business Meeting II Minutes

I. Call to re-convene Bond reconvened the business meeting at 2:17 pm on December 5, 2009. II. Election of Officers The slate of nominees for President-elect and Councilors was announced and the membership voted by secret ballot. Gary Sieck was elected President-elect. Patricia Molina and Michael Reid were elected Councilors with terms ending in 2012. III. 2010 ACDP Meeting R. Clinton Webb, ACDP President-elect, announced that the 2010 ACDP meeting would be held December 2-5, 2010 at the Hyatt Regency Coconut Point Resort and Spa in Bonita Springs, FL. Attendees suggested that a portion of the meeting be devoted to new chairs. Suggestions included 1) allowing new chairs or new attendees more of an opportunity to introduce themselves to the group, 2) initiate a type of mentoring program to pair more experienced chairs with new chairs for a year to help with their transition in the new job, and 3) have sessions where chairs can discuss issues they are facing in their departments and institutions in breakout groups and then report back to the entire group. Mazzaschi mentioned that many clinical societies start their annual meetings with half day of training for new chairs. In addition, he noted that AAMC offers new chair training workshops. IV. Adjournment The meeting was adjourned at 2:40 pm. Respectfully submitted, Christopher Cheeseman Secretary-Treasurer

Association of Chairs of Departments of PhysiologyRevenue and Expenses and Changes in Net Assets

Year to Date as of September 30, 2010

2010 YTDRevenue: Annual Meeting General Totals at 9/30/10 Totals at 9/30/09 Incr/(Decr)

Meeting Registration 1,450$ -$ 1,450$ 17,825$ (16,375)$ Dues Income - 23,750 23,750 30,250 (6,500) Interest Income - 47 47 39 8

Total Revenue 1,450 23,797 25,247 48,114 (22,867)

Expenses:Professional Services - - - - - Supplies - - - 98 (98) Printing - - - - - Postage Expense - - - 119 (119) Telephone - 284 284 284 - Credit Card Processing Fees - 477 477 983 (506) Travel - 2,166 2,166 2,961 (795) Dues Expense - Associations - 1,144 1,144 1,130 14 Meetings Expense - - - 1,828 (1,828)

Total Expenses - 4,071 4,071 7,403 (3,332)

Net Revenue/(Expenses) 1,450 19,726 21,176 40,711 (19,535)

Net Assets, Beginning of Year 56,539 67,913 (11,374)

Net Assets, End of Period 77,715$ 108,624$ (30,909)$

Report 100930.xlsx

CAS Activities Report November 8, 2010 This edition of the CAS Activities Report provides background on the Council of Academic Societies and on current and previous CAS initiatives as a service to both new and current CAS Representatives, as well as for those unfamiliar with the CAS.

============== The Council of Academic Societies (CAS) is one of the three leadership councils of the Association of American Medical Colleges (AAMC), along with the Council of Deans and the Council of Teaching Hospitals and Health Systems. The CAS is presently comprised of nearly 90 academic societies devoted to biomedical and behavioral research, medical education, and patient care. The collective membership of these societies include essentially all faculty members and scientists in American medical schools engaged in life sciences research, research training, clinical service, and medical education. The CAS, though diverse in membership, is a powerful forum for discussing and exchanging information of common interest to medical school faculty and for evaluating and recommending policy initiatives to the Association. Also part of the AAMC leadership are two “organizations,” one representing students and the other residents. Residents are appointed to the AAMC Organization of Resident Representatives by specialty-specific program director societies that are members of the CAS. Each such society appoints two residents who serve staggered terms to ensure leadership continuity. CAS Membership Criteria: In late 2004, the CAS Administrative Board asked the Membership Committee to develop criteria for membership in the CAS. The Committee developed the following principles that were accepted by the CAS Administrative Board at its meeting in February 2006: The CAS represents faculty’s voice within the AAMC governance structure and to the

extent possible, member societies should represent faculty with medical school appointments. Although medical school faculty membership may represent only a portion of the membership of some societies (and potential member societies), membership in the CAS may still be appropriate, especially if medical school faculty members are organized in a sub-unit (such as a section or council).

Societies representing institutional units, such as colleges and programs, should not be considered for membership. Organizations that represent both faculty and programs may

CAS Activities Report November 8, 2010 Page 2

still be appropriate, especially if medical school faculty members are organized in a sub-unit (such as a section or council).

Membership in the CAS by organizations representing academic medical center faculty outside of the medical school, should not be permitted. This would represent a fundamental change in AAMC membership and such an expansion should be a corporate decision made only at the explicit direction of AAMC governance.

Membership by organizations representing medical school faculty, but whose mission is focused on non-medical school issues and programs, should be discouraged. Although the mission of these organizations is laudable, their presence may dilute the CAS’s focus.

CAS Representatives: Each CAS member society may designate two representatives to the CAS, which meets semi-annually; once during the AAMC annual meeting in the fall and separately in the spring. CAS meetings engage national leaders from academe, industry, and government that inform the deliberations of the Council. Amendments to the CAS Rules and Regulations unanimously approved by CAS representatives by electronic ballot in May 2009, set new qualifications for CAS representatives. The most significant changes were requiring that CAS representatives be faculty members and that terms of office be three years, with the possibility of reappointment. The AAMC Board of Directors approved the proposed revisions at its meeting on June 25, 2009. The CAS Leadership: The CAS elects its own chairperson. Anthony Meyer, M.D., Ph.D., is the 2009-2010 Chair of the CAS. He is Chair of the Department of Surgery at the University of North Carolina, Chapel Hill School of Medicine and a representative of the Society of Surgical Chairs. His term as chair runs through the 2010 AAMC Annual Meeting. The CAS Chair-Elect is James M. Crawford, M.D., Ph.D., Chair of the Department of Pathology and Laboratory Medicine, and Senior Vice President for Laboratory Services, at the North Shore-Long Island Jewish Health System (NSLIJ). He is also the founding Chair of the Department of Pathology at the Hofstra University School of Medicine and a representative of the Association of Pathology Chairs. Randall K. Holmes, M.D., Ph.D., is the current Past Chair of the CAS. He is Chair of the Department of Microbiology, University of Colorado School of Medicine, and a representative of the Association of Medical School Microbiology and Immunology Chairs. The CAS Administrative Board: CAS representatives elect 12 of their colleagues to serve on the CAS Administrative Board, which formulates the programs of the full Council and acts on its behalf on Association business and policy initiatives. The CAS Administrative Board is the key leadership mechanism by which the CAS is engaged in AAMC policy and governance issues. The Administrative Board has four regularly scheduled meetings a year, in December, March (at the CAS Spring Meeting), June and September. In addition, the Administrative Board holds a monthly conference call during those months it does not have a scheduled face-to-face meeting. Recent topics considered by the CAS Administrative Board include:

A review of AAMC’s strategic goals and objectives related to discovery;


A discussion and critique of an assessment of AAMC member satisfaction and engagement, and a detailed review of the assessment results;

A review of the AAMC Faculty Forward Program; Consideration of the role of faculty leadership in respecting various disciplines and

specialties; AAMC’s role in interprofessional health education and practice; The role of the CAS and especially the CAS Administrative Board in the new AAMC

governance structure; Efforts to provide greater opportunities for CAS representatives to be engaged in AAMC

and CAS activities; Improving bi-directional communication to and from CAS representatives and societies; The CAS’s role in communicating to faculty more generally; The draft (and now final) ACGME Resident Duty Hour policy changes; AAMC initiatives on health care quality; The MR5 review of the MCAT; and Consideration of various proposed AAMC policies and programs.

The Administrative Board also engages outside leaders and experts, as appropriate. For example, at the June 2010 meeting of the Administrative Board, Dr. Allan S. Lichter, CEO of the American Society for Clinical Oncology, joined the Administrative Board to discuss the recently issued Council of Medical Specialty Societies voluntary code for society interactions with industry. At its September 2010 meeting, the CAS Administrative Board held a special joint session with the Organization of Resident Representatives Administrative Board on “The War for Talent” and whether academic medicine can compete for the faculty and staff necessary to sustain the enterprise. The CAS Administrative Board has also focused on succession planning to help ensure that a new generation of faculty leaders is prepared to govern and lead the CAS and AAMC. Engaging the full spectrum of faculty voices has become a CAS leadership priority. AAMC Board of Directors: In 2007 and 2008, the AAMC Executive Committee and Executive Council undertook a major review of the AAMC governance. As a result of the review, the AAMC Assembly and Executive Committee were abolished and replaced with a 17-member Board of Directors. The Chair and Chair-Elect of the CAS have designated slots on the Board. In addition to other designated slots, open positions are available based on the skills deemed necessary by the nominating committee. In addition, a public member serves on the Board. During the 2009-2010 term, three CAS representatives served on the Board: Drs. Anthony Meyer, James Crawford, and J. Lloyd Michener. Recent actions by the Board of Directors include:

Approval of a one-year pilot of a Board of Directors Liaison Program;


Endorsement in concept of the draft discussion paper "Roles and Responsibilities of the Administrative Boards of the AAMC Councils and Organizations and the Steering Committees of Groups;

Approval of new AAMC medical school and teaching hospital members to the COD and COTH, respectively;

Approval of CAS membership to the Academy on Violence and Abuse, and to the American Academy of Hospice and Palliative Medicine;

Endorsement of the MR5 (MCAT) review process (several CAS representatives serve on the review panel); and

Agreement to establish a building fund for the AAMC to move into active market exploration for a new facility.

AAMC Leadership Forum: Another major decision of the AAMC Governance Review was the creation of the AAMC Leadership Forum. The Leadership Forum has met four times: December 2008 (strengthening public accountability and dealing with our conflicts of interest and “whither goest primary care?”); June 2009 (health care reform); December 2009 (alignment of the medical school and teaching hospital missions), and; June 2010 (health care reform). At each Forum meeting, more than 80 constituents representing more than 60 member institutions and all AAMC Councils, Organizations, Groups, and Advisory Panels were represented. Another Leadership Forum session will be held in December 2010 on medical education (“creating the physician I need in the system I want”). The CAS is allotted five slots at the Leadership Forum, but additional CAS representatives serve through their participation on the AAMC Board or as representatives of AAMC Groups. CAS Committees: As part of the CAS Review conducted in 2008 by the CAS Administrative Board, a restructuring of CAS committees was approved. The CAS Nominating Committee is set in the CAS Rules and Regulations. Other committees and work groups are formed by the Administrative Board, with membership designation by the CAS Chair. The 2010 CAS Nominating Committee is chaired by CAS Past-Chair Dr. Randall Holmes. The Committee will present its report and a slate of candidates for the CAS Administrative Board and other leadership positions at the CAS Business Meeting at the AAMC Annual Meeting in November, 2010. The CAS Program Committee met in August in New York City to begin planning the 2011 CAS Spring Meeting. The Committee is chaired by Dr. James Crawford, the Chair-Elect of the CAS. The CAS Leadership Development Committee is chaired by Robert Sokol, M.D., Distinguished Professor of Obstetrics & Gynecology, Director, C.S. Mott Center for Human Growth and Development, Wayne State University C.S., Mott Center for Human Growth and Development. The Committee has met three times in 2010, and framed its discussions of leadership development in terms of three circles of engagement: 1) providing leadership development to

CAS Activities Report November 8, 2010 Page 5 faculty generally; 2) providing leadership development skills to existing faculty leaders; and 3) providing leadership development pathways for CAS representatives. While most major leadership development programs are sponsored by AAMC, the CAS Leadership Development Committee and the Administrative Board are valuable resources to the AAMC staff directly responsible for these programs. There are internal discussions about expanding the scope, format, and substance of the AAMC’s leadership development offerings and the CAS will serve as a valuable partner as these initiatives take shape. The Committee has developed a proposal for a leadership development session at the CAS Spring Meeting that is being advanced to the Program Committee. The Committee has been discussing, as has the Membership Committee, how to engage mid-career faculty in the CAS. A draft CAS Fellowship proposal was reviewed by the Committee at its November 2010 meeting. A revised version will be considered by the Administrative Board, after the CAS Membership Committee completes its review. The CAS Membership Committee is chaired by Evelyn C. Granieri, M.D., M.P.H., Chief, Division of Geriatric Medicine and Aging, Columbia University College of Physicians and Surgeons. The Committee has met three times in 2010 and has reviewed the membership application of the Academy on Violence and Abuse and recommended that the society be accepted in the CAS. The panel used the occasion to revise the CAS Membership Application Form. Subsequently, a membership application was received and approved from the American Academy of Hospice and Palliative Medicine. A membership application from another academic society is currently under review. A draft CAS Fellowship proposal was reviewed by the Committee during its August 2010 meeting. A revised proposal is currently under review and will be considered by the Administrative Board, after the CAS Membership Committee completes another review. AAMC staff, at the request of the Committee, developed demographic data on CAS representatives based on data contained in the AAMC Faculty Roster System. The Committee analyzed the results to consider other initiatives to insure that the CAS reflects faculty. As a result, additional steps are being taken to encourage mid-career faculty to participate in CAS programs and meetings. The Administrative Board in June 2010 formed the CAS Working Group on Faculty Innovations, chaired by Lee Fleisher, Chair of Anesthesiology, University of Pennsylvania School of Medicine. The CAS, as a voice for faculty through academic and scientific societies, is seeking to provide a forum for faculty to highlight, discuss, and facilitate thoughtful, feasible, forward-looking innovations – which may range from collecting and disseminating on-going innovations, to recommending to AAMC how it can promote innovations. This CAS initiative will advance several of the AAMC’s strategic goals, including helping members identify and disseminate promising practices for organizational effectiveness and improvement, highlight innovative

CAS Activities Report November 8, 2010 Page 6 management practices, and lead innovation in critical mission areas. The Working Group held its initial meeting in November 2010 and discussed objectives for the panel, a shared definition of innovation, and possible development and dissemination strategies. A face-to-face meeting of the panel is being scheduled for January 2011. Upcoming CAS Membership Meetings: The CAS is sponsoring or co-sponsoring five plenary sessions at the 2010 AAMC Annual Meeting in Washington, DC. The sessions are:

Balancing an Academic Career in Medicine and Family Responsibilities: “Can It Be Done?”

Advancing Values While Advancing Research: Educating New Scientists Reconsidering “Scholarship Reconsidered” Scientific Exchange: At the Interface of Academic Societies, Continuing Medical

Education, and Industry Multiple Facets to Sustainable Research Careers for Women

Recent CAS Membership Meetings: The CAS Spring Meeting is a powerful forum for discussing and exchanging information of common interest to the CAS membership and for evaluating and recommending policy initiatives for the Association. The deliberations also play a key role in shaping the public policy agenda of the member societies. The theme of the 2010 CAS Spring Meeting, held March 4-6, 2010 in Austin, Texas was “The Role of Faculty Leaders in Aligning Priorities, Perceptions, and Missions.” A summary of the meeting is available on the CAS Private Web Page (contact: <[email protected]> for connection details). Other recent CAS meeting themes have been:

2009: Assessing the Forces of Change: Finding Allies in Turbulent Times 2008: Enhancing Academic Values in a Time of Change and Opportunity 2007: The Role of Research in Training the Next Generation of Physicians 2006: Increasing Physician Supply; Enhancing Quality Medical Education 2005: Tomorrow's doctors, Tomorrow's Cures: Envisioning the Future 2004: Changing Academic Medicine's Priorities from Growth to Quality 2003: The Scientific Basis of Medicine: Preserving Curiosity and Rigor 2002: Changing Values: the Evolving Art and Science of Medicine 2001: 21st Century Medicine: Getting IT Done in Research, Education and Healthcare

Specific topic discussions at other recent CAS Meeting include: 2010 CAS Spring Meeting (Austin)

Institutional Identities Faculty Leaders and Respect Health Care Reform and Academic Medicine


Faculty Leadership Development, Survival and Growth Crucial Conversations in Academic Life Recruiting and Retaining Academic Leaders

2009 AAMC Annual Meeting (Boston) Scientific Foundations for Future Physicians Improving the Health of Communities - The Role of Primary Care Research Comparative Effectiveness Research: The Opportunities and Challenges for

Academic Medicine 2009 CAS Spring Meeting (Charleston)

Health Care Reform: Assessing the Political, Economic and Consumer Forces Allied for Change

Physician Salaries: Equity, Incentives and Health System Reform Research, Accreditation and Accountability: The Role of Faculty Leaders in

Regulating the Profession Forces Driving Curriculum Change Comprehensive Review of the USMLE

2008 AAMC Annual Meeting (San Antonio) Financing CME: Evolving Questions, Evolving Models Complying with the NIH Public Access Policy The Baby Boomer Time Bomb

2008 CAS Spring Meeting (New Orleans) The Comprehensive Review of the United States Medical Licensing Examination The Veterans Administration and Academic Medicine: Opportunities and Challenges

for Faculty Katrina and the Academic Missions: Lessons Learned Financial Conflicts of Interest in Academic Medicine: Research, Education, and

Practice 2007 AAMC Annual Meeting (Washington)

Patients (Real and Simulated) and Medical Education The Primary Focus of Medical Education: Learner or Patient? Faculty and Learner Autonomy and Supervision: Finding the Balance

2007 CAS Spring Meeting (Long Beach) The Evolution of the Research, Medical Education and Clinical Service Missions in

LCME-Accredited Medical Schools Integrating the Research and Education Missions – Value Added for Future

Practitioners The Cost and Cost Effectiveness of Creating a Research Environment that

Complements the Medical Education Mission Tomorrow’s Practitioners - Consumers of New Knowledge in the

Genomic/Proteomic Age

CAS Activities Report November 8, 2010 Page 8 Future Meetings of Interest to CAS Representatives:

2011 CAS Spring Meeting, March 3-5, 2011, Providence, RI 2011 AAMC Annual Meeting, November 4-9, 2011, Denver, CO 2012 CAS Spring Meeting, March 8-10, 2012, Santa Fe, NM 2012 AAMC Annual Meeting, November 2-7, 2012, San Francisco, CA 2013 AAMC Annual Meeting, November 1-6, 2013, Philadelphia, PA

CAS Workshops and Special Meetings: In addition to regular membership meetings, the CAS sponsors workshops and other special meetings. Summaries of these meetings are routinely prepared and posted on the CAS web site. Suggestions of topics for additional workshops are welcome. Some of the recent CAS workshops are discussed below: CAS-APM Forum on the Physician-Scientist Workforce: A Workshop for Clinical Faculty Leaders: The Council of Academic Societies and the Association of Professors of Medicine sponsored a full day workshop on October 31, 2008 on issues related to the physician-scientist workforce. The CAS-APM forum, “The Physician-Scientist Workforce: A Workshop for Clinical Faculty Leaders,” assembled leaders of the academic, medical, and research communities to address issues surrounding the development, nurturing, and sustenance of physician-scientists. Participants included leaders of department chair organizations in dermatology, family medicine, internal medicine, neurology, pathology, pediatrics, physiatry, psychiatry, radiology, and surgery; deans of medical schools and associate deans for research; and directors of Clinical and Translational Science Award programs. The goals of this forum were to: (1) encourage and prepare participants to be change agents in improving the development and retention of physician-scientists; and (2) encourage stakeholders from a variety of clinical disciplines to work collectively on a national agenda for revitalizing interest in physician-scientist careers. Through a series of presentations focusing on repairing the “leaking” pipeline, diversity and gender issues, mentoring, and overcoming organizational barriers, speakers and participants engaged in vigorous discussion about how institutions and other members within the academic, medical, and research communities have responded and can respond to solving the problem of recruiting and maintaining a robust clinical investigator workforce. A report has been prepared that focuses on the speakers’ presentations, institutional innovations, and the participants’ conclusions and recommendations for implementing these solutions. While the CAS-APM forum was a useful step in establishing a cooperative effort to advance this agenda, much is left to accomplish. Meeting of Selected CAS Society Executive Directors on the Economic Crisis: Executive Directors and other senior staff members of 14 academic societies belonging to the CAS met February 20, 2009 for an informal, off-the-record discussion on how the economic crisis was affecting the health of academic societies and their ability to meet their missions. Some of the issues discussed included trends related to reserve funds, member meeting attendance, exhibitor space rental income, meeting site negotiations, journal revenue, corporate memberships and

CAS Activities Report November 8, 2010 Page 9 sponsorships, society operations, and member and leadership communications. A short summary of the discussions has been posted on the CAS Private Web Site. CAS Workshop on Academic and Scientific Society Interactions with Industry: The Council of Academic Societies sponsored a full-day workshop on November 2, 2007 on “Academic and Scientific Society Interactions with Industry.” The goals of the workshop were to discuss the range of corporate involvement in academic and scientific society activities and how such interactions are and should be managed to protect professional values. The workshop began with a presentation on the evolving policy environment regarding faculty, institutions and conflicts of interest. Leaders from two societies (the American College of Neuropsychopharmacology and the American Society of Clinical Oncology) discussed their efforts to manage industry interactions in their societies’ wide array of activities. A luncheon presentation focused on legal issues in managing association-industry interactions. Four breakout sessions followed on specific domains of corporate-society interactions (publications and supplements; lectures and sponsored meeting programs; clinical guidelines; and, corporate sponsorship of other society activities). A discussion of FASEB’s current activities was followed by a broad discussion of possible future actions. A summary of the meeting is available on the CAS Private Web Site. The Chicago Collaborative: The Chicago Collaborative evolved from a meeting of representatives of key science, technology, and medicine (STM) publisher organizations and the Association of Academic Health Sciences Libraries (AAHSL). The group first met in Chicago on May 22, 2008, to discuss the formation of a new collaboration emphasizing open communication and shared common interests around the grand challenges and opportunities of scholarly communication. The CAS was invited to participate in this initiative given the scholarly communication activities of its member societies (see below) and the CAS’s initiatives to both describe the state of scholarship dissemination by academic societies as well as to promote a broader definition of scholarship within the academe. The Collaborative is next meeting on November 10, 2010, in a meeting sponsored by the CAS. Other Completed Programs and Initiatives of Note: Responsible Conduct of Research: In 2002, the AAMC was awarded a cooperative agreement from the DHHS Office of Research Integrity (ORI) to fund responsible conduct of research (RCR) activities proposed and sponsored by academic societies. Although not limited to CAS member societies, they clearly are the focus of the program. Subsequently, ORI extended the program for four years. More than $1,000,000 was distributed via 39 awards to 36 different academic and scientific societies. The program is no longer accepting new applications. Basic Science Leadership Forum: This entity was designed to give a voice to the basic science chair societies, but was broadened to serve now as a venue for discussing issues related to basic science and basic scientists in academic medicine. The Forum organized the first national meeting of basic science chairs in Philadelphia in October 2002. A second national conference

CAS Activities Report November 8, 2010 Page 10 was held in October 2005 in Salt Lake City. All presentations made at these meetings, along with summaries of the breakout session discussions, were posted on the CAS Private Web Page. The 2005 meeting presentation topics included:

Building a Vision for Basic Science in the Medical School of Tomorrow The Changing Organization of Biomedical Research Creating an Environment that Promotes Faculty Productivity Graduate and Medical Education and the Role of Basic Science Chairs Institutional Expectations of Chairs; Legal Issues for Chairs NIH Funding, Extramural Research and Peer Review Managing the Hard Landing: Case Studies

The Forum has convened several additional small meetings of basic science department leaders and faculty members over the years to discuss issues of concern. Topics discussed included the role of basic science in advancing the medical education mission; issues related to basic science instruction in light of the expansion of medical school class sizes; graduate and postdoctoral education, including the expansion of umbrella programs and the reduction in training slots as a consequence of flat research funding; and issues related to the NIH funding situation, including bridge funding and the impact on faculty development. In 2009, the CAS Administrative Board conducted a survey of the leadership of the basic science chair societies, seeking their views on the advisability of scheduling another national meeting of basic science chairs. The Administrative Board decided not to schedule another meeting in the near term due to the economic crisis and the uncertainty of meeting travel funds. The decision will be revisited in the near future. Scholarship Dissemination Project: The goal of this completed project was “to provide faculty, staff and students in AAMC member schools, as well as members of CAS societies, with a clearer picture of the significant changes that are taking place in the medical and biological sciences as scholarly communication moves from predominantly print to online electronic journals.” In addition, the results of this effort will inform the Association’s policy deliberations on publishing issues. Gary Byrd, Ph.D., and Shelley Bader, Ed.D., led the project. A Project Advisory Committee was formed and included representative editors and publishers of CAS society journals, academic health sciences library directors, and faculty. Utilizing the services of academic health center librarians and a graduate student, a database was completed with basic bibliographic, pricing and subscription data for the 101 print and/or electronic journal titles currently published or sponsored by CAS member societies. Additional documents were collected describing copyright and other editorial policies associated with each journal. This data was verified by the CAS societies. The Project Advisory Committee developed a number of additional categories of information they wanted to investigate about the journal publishing activities of CAS member societies,

CAS Activities Report November 8, 2010 Page 11 including factors influencing academic library subscribers to these journals. A web-based survey instrument was composed and tested. Subsequently, a very similar survey instrument composed by the American Association for the Advancement of Science, the Association of Learned and Professional Scholarly Publishers, and HighWire Press came to the panel’s attention. Those groups agreed to expand their sample to include all of the CAS societies that publish journals. The preliminary results of the survey were shared with the CAS Administrative Board in February 2005 and with the membership in March 2005 at the CAS Spring Meeting. The Administrative Board accepted the final report from the survey consultant in September 2005 and a summary was distributed to all CAS society representatives. The summary and the full report have been posted on the CAS Private Web Page (contact <[email protected]> for connection details). Task Force on Dual Degree Students, Programs and Faculty: The Task Force, chaired by Dr. Lynn Eckhert, was charged with exploring the impact of dual degree programs on the medical school enterprise. The Task Force was provided with extensive data from the Faculty Roster System (FRS)/ Faculty Administrative Management On-line User System (FAMOUS), the Medical Student Records System, the Curriculum Management & Information Tool (CurrMIT), the LCME, and the Matriculating Student (MSQ) and Graduate (GQ) Questionnaires. The Committee also received various published and reviewed scholarly works related to dual degree programs. The Committee also discussed and provided substantive comments on the Division of Medical Education’s study of M.D./M.P.H. programs. The Task Force’s final report provides a scan of the existing data, discusses the Task Force’s observations about the data, and makes some recommendations to AAMC staff and governance. The CAS Administrative Board accepted the Task Force’s report in February 2005. It was transmitted to the AAMC leadership and the Executive Staff for their consideration and was shared with the membership at the CAS Spring Meeting. The report has been posted on the CAS Private Web Page (contact <[email protected]> for connection details). Task Force on Faculty Leadership: In 2005 the CAS Chairs Task Force was re-named the Task Force on Faculty Leadership. Dr. Lloyd Michener chaired the Task Force. The Task Force developed the very useful Chairs Objectives Project report, which outlines the knowledge, values, skills, and attributes of the ideal department chair. Chair search committees at many medical schools have found this a very useful resource. The CAS Leadership Development Committee has assumed the charge of this Task Force. CAS Communication Activities: The CAS listserve is an important tool for CAS representatives. This news service, exclusively for CAS representatives, provides timely and important information that helps make CAS representatives among the most informed faculty on campus. Additional listserves are operated for clinical and basic science department chairs under the CAS umbrella. Contact <[email protected]> for subscription details.

CAS Activities Report November 8, 2010 Page 12 Through the CAS, a variety of valuable AAMC resources have been made available to faculty leaders. The CAS private web page is currently being redesigned as part of an overall AAMC web page revision. The CAS web site features three specialty pages that provide resources to chairs, program directors and clerkship directors. These private, password-protected internet web sites offer a number of useful tools, databases, and information resources of great value to faculty leaders. ==================================================================== Comments and inquiries on CAS activities should be directed to Tony Mazzaschi at 202-828-0059 or <[email protected]>.

------ Forwarded Message From: "William F. Jackson" <[email protected]> Date: Tue, 23 Nov 2010 11:13:33 -0500 To: <[email protected]> Subject: National Directors of Graduate Studies Meeting Dear Clinton, I am writing to you in your position as chair of the Association of Chairs of Departments of Physiology (ACDP) on behalf of the organizing committee of the National Directors of Graduate Studies (NDOGS) meeting that will be held this summer, July 7-9, 2011 at MSU (see attached draft program). This will be the fourth biannual meeting of this group and we are excited that this meeting will include directors of graduate programs from physiology departments as well as the usual pharmacology department contingent. Attached is We are in the process of gathering funds to defray the cost of the meeting so that we do not have to charge a registration fee. The Association of Medical School Pharmacology Chairs (AMSPC) has agreed to provide $1,500 to help defray the cost of Breakfasts, Lunches and Coffee breaks. Would the ACDP also be interested in contributing to the meeting? A similar donation to that provided by AMSPC would be great ($1,500), but any amount would be appreciated. Let me know if additional information is required. Thanks, in advance for your support. Bill -- William F. Jackson, Ph.D. Professor Dept. of Pharmacology & Toxicology Michigan State University B420 Life Sciences Bldg. East Lansing, MI 48824-1317 Phone: 517-353-5476 FAX: 517-353-9398 E-mail: [email protected]

NDOGS Meeting Outline and Tentative Schedule July 7th Noon Registration Thursday afternoon 2:00 - 2:30 Opening Address and Welcome - MSU 2:30 - 3:15 Report from The National Biomedical Workforce Committee.

(Representative from this National Academy of Sciences Committee) – Roger Chaulkley 3:15 - 4:00 ORPHEUS Report. Ph.D. Organization for Ph.D Education in Biomedicine and Health Sciences

in the European System – Joey Barnett, Vanderbilt 4:00 - 4:30 Break 4:30 - 5:15 Fostering Discipline Visibility at the National Level as a Tool for Recruitment – APS 5:15 – 5:45 Recruiting International Students 5:45 – 6:30 Using GREs to Evaluate Students and/or Evaluating International Students – Someone from

ETS to talk about GREs 6:30-7:00 Break Thursday evening 7:00– Keynote Speech and Dinner (changing environment for science?) – National Policy – Dr. Ann

Bonham, AAMC's Chief Scientific Officer July 8th Friday morning 9:00 - 9:30 Careers 1 talk based on growth areas identified in NAS report – what are the most important

aspects of training in their jobs – Physiology focused 9:30 - 10:00 Careers 2 talk based on growth areas identified in NAS report – Pharmacology focused 10:00 - 10:30 Careers 3 talk based on growth areas identified in NAS report – Physiology/Pharmacology

focussed 10:30 - 11:00 Break 11:00 - 11:45 Short Courses in Integrative & Organ System Sciences – Short Course Directors 11:45 - 12:30 Undergraduate Programs and Initiatives in Pharmacology and Physiology 12:30 - 1:30 Lunch (provided) Friday afternoon 1:30 - 2:00 Web based approaches to graduate education – MSU – others? Margaret Scofield 2:00 - 3:30 Concurrent Sessions with coffee and snacks

Graduate Curriculum Issues in Pharmacology / defining and meeting objectives Graduate Curriculum Issues in Physiology / defining and meeting objectives – APS

(Roundtable presentations from representative programs chosen to illustrate different approaches to issues such as didactic curricula, independent learning, and qualifying examinations)

2:00 - 2:30 New RCR guidelines – NIGMS person give overview – then a couple of people from programs - 2:30 - 3:30 Update on NIGMS strategic planning – Allison Cole, NIGMS and – Marsha Mattyas, APS –

minority recruitment Update and Overview of Predoctoral Training Programs in Pharmacology and Physiology -

NIGMS staff - Program officer 3:30 - 4:00 Initiatives for Integrative Biology in Pediatrics - CHD representatives 4:00 - 5:30 Move to Break out Sessions (Each session is for one half hour and is chosen by participants,

drinks and snacks are available. We often schedule multiple sessions on popular topics so everyone has a chance to participate or remain for extended discussions of a topic.)

Break Out Sessions

Undergraduate Programs

Integrative Pharmacology

Pharmacology for Grad students

Recruiting and evaluating international students

ORPHEUS Standards for Ph.D. training

Careers

Pediatric Pharmacology Initiatives

NIGMS strategic plan & NIGMS training programs

Pharmacology for Grad students

Physiology for Grad students

ORPHEUS Standards for Ph.D. training

Report from The National Biomedical Workforce Committee

Recruiting and evaluating international students

NIGMS strategic plan & NIGMS training programs

Careers Physiology for Grad students

Integrative Pharmacology

Report from The National Biomedical Workforce Committee

Minority Recruitment

Friday evening 6:00 - 7:30 Graduate student poster sessions (MSU students) with wine and cheese reception 7:30 Dinner on your own Saturday July 9th Morning 8:30 - 11:30 Optional Workshop on NIH Training Grants (Informal presentations and discussions by NIGMS staff and currently funded program directors for those

interested in obtaining NIH funding)

4th Annual Arthur C. Guyton Lectureship Ferid Murad, M.D., Ph.D.

Professor and Director Emeritus The Brown Foundation Institute of Molecular Medicine Director, IMM Center for Cell Signaling Texas Nobel Scholar, The University of Texas at Houston Director, UT Health Science Center at Houston Program in Intracellular Signaling= 1998 Nobel Laureate in Physiology or Medicine

“Discovery of Nitric Oxide and Cyclic GMP in Cell Signaling and Their Role in Drug Development”

Ferid Murad is Director Emeritus of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Director of the IMM Center for Cell Signaling, Regental Professor and John S. Dunn Sr. Distinguished Chair in Physiology and Medicine, Texas Nobel Scholar at the University of Texas at Houston, and Director of the UT Health Science Center at Houston Program in Intracellular Signaling.

Dr. Murad completed his undergraduate work at DePauw University and received his M.D. and Ph.D. from Case Western Reserve University. He had a medical residency at Massachusetts General Hospital and a fellowship at NIH in the Heart Institute. He was on the faculty at the University of Virginia 1970‐81 as Director of the Clinical Research Center and Director of the Division of Clinical Pharmacology with appointments in Medicine and Pharmacology. He was Chief of Medicine at Palo Alto Veterans Hospital 1981‐88, Associate Chairman of Medicine 1982‐86 and Chairman of Medicine 1986‐88 at Stanford University. He was Vice President of Research and Development at Abbott Laboratories 1988‐93 and Professor at Northwestern University.

Dr. Murad has been active in both academic medicine and industry throughout his distinguished career. He has founded or co‐founded five biotechnology companies and has advised many cities and government leaders about technology development. His work has concentrated on the field of cell signaling and signal transduction systems.

In 1998, Dr. Murad received the Nobel Prize in Medicine for his work with nitric oxide ‐ a colorless, odorless gas that signals blood vessels to relax and widen, which in turns lowers blood pressure. He continues research which leads to a better understanding of how information is transmitted between cells.

Among his many other awards and honors, Dr. Murad received the prestigious Albert and Mary Lasker Basic Medical Research Award in 1996, the American Heart Association Ciba Award in 1988, and the Baxter Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2000. He also received the American Society of Clinical Pharmacology Distinguished Research Prize in 2005 and the President's Scholar Award from the University of Texas‐Houston Health Science Center in 2006.

He is a member of the National Academy of Sciences, a member of the Institute of Medicine of the National Academy of Sciences, Fellow of the American Academy of Arts and Sciences, member of Texas Academy of Medicine, Engineering and Science Technology. He is also a member of several foreign academies and is an Honorary or Adjunct Professor at a number of universities. Dr. Murad also serves on the Board of Directors or Scientific Advisory Boards of a number of public and private companies and various foundations and universities. About 140 trainees have worked with him in his laboratories who are currently academic or pharmaceutical industry leaders around the world.

Research Projects:

Dr. Murad's research with cell signaling focuses on the nitric oxide/cyclic GMP pathways to identify novel molecular pathways and targets that can lead to the discovery and development of novel therapeutic agents. His laboratory in the IMM is typically 18 to 20 scientists. He also has a similar sized laboratory at the Shanghai University examining the effects of Traditional Chinese medicines on the NO/cGMP pathways.

Previous Guyton Lecturers: 2009 Helen Hobbs University of Texas Southwestern Medical Center 2008 Eric Olson University of Texas Southwestern Medical Center 2007 H. Lee Sweeney

University of Pennsylvania

ACDP Speaker Biosketches

R. Kevin Grigsby, DSW Senior Director Organizational Leadership Development Association of American Medical Colleges R. Kevin Grigsby, MSW, DSW is Senior Director of Organizational Leadership Development at the Association of American Medical Colleges. He served as Vice Dean for Faculty and Administrative Affairs from 2000 – 2009 at Penn State College of Medicine in Hershey, Pennsylvania, where he continues to hold an academic appointment as Professor of Psychiatry. Dr. Grigsby’s clinical experience includes a history of program planning, implementation,

and evaluation in the area of innovative home and community based health and mental health services. His clinical practice experience has been primarily in under served rural and inner city areas and includes perinatal intervention with substance abusing women, mental health service delivery to children and adolescents in shelter care, provision of home‐based services to parents and children with HIV related illnesses, and the use of advanced telecommunications technology in health services delivery. During the past decade, the focus of Dr. Grigsby’s work shifted to organizational development in academic health centers. Developing a future‐oriented perspective in academic leaders and the alignment of resources with missions are focus areas. Dr. Grigsby remains active in promoting effective interpersonal communication within academic health centers and in implementing alternative conflict resolution/management strategies at the department and institutional levels. He has been instrumental in developing career development programs and is an Editorial Advisory Board Member and frequent contributor to the AAMC publication Academic Physician and Scientist. The use of teams and other nontraditional organizational models in higher education settings is another area of scholarship. As an expert on the use of teams in academic health centers, Dr. Grigsby has presented at regional and national conferences and has consulted with a number of academic health centers and professional organizations. He and his colleagues published an account of the use of teams to unify the clinical, academic, and research enterprises in an academic health center. This approach was instrumental in breaking down barriers that typically separate academic departments and resulted in reducing traditional barriers between employees and management, promoting faculty and staff participation in decision‐making processes, and solving organizational problems that seemed to be intractable in the past. At the AAMC, he and his team are working to create programs to improve individual performance of faculty and leaders at academic medical centers, to address the needs of women and underrepresented minorities at academic medical centers, and to link individual professional development to improved organizational performance.

ACDP Meeting December 2‐5, 2010; Hyatt Regency Coconut Point, Bonita Springs, Florida

J.R. Haywood, Ph.D. Chair, Dept. of Physiology & Pharmacology & Toxicology Michigan State University J.R. Haywood, Ph.D. is Chair of the Department of Physiology, and Assistant Vice President for the Office of Regulatory Affairs at Michigan State University. In his Regulatory Affairs position, he is responsible for human research protection, animal care, and environmental health and safety. He also holds an Adjunct Scientist position at the Southwest Foundation for Biomedical Research in San Antonio, Texas. Dr. Haywood joined Michigan State University in 2002 after rising to

Professor in the Department of Pharmacology at the University of Texas Health Science Center at San Antonio. As Chair of Pharmacology and Toxicology, he has overseen an expansion of research funding; helped establish hands‐on opportunities for students in integrative physiology, pharmacology and toxicology; and directed the implementation of an online Professional Science Masters in Integrative Pharmacology and an online Master of Science in Pharmacology and Toxicology. The programs offer more than 15 courses to students throughout the United States. Dr. Haywood has been active in the American Physiological Society serving on its Council, as Chair of the Animal Care and Experimentation and Public Affairs Committees, and currently as representative to the FASEB Board of Directors. He has also served in the leadership of the High Blood Pressure Council of the American Heart Association. Dr. Haywood has been an advocate for the humane care of animals in research and teaching by serving on the Council of Association for the Assessment and Accreditation of Laboratory Animal Care, International and the Board of Governors of the International Council of Laboratory Animal Science. He has made numerous presentations at animal research ethics meetings over the years. He is currently co‐chairing an update of the International Guiding Principles for the Use of Animals in Research. Dr. Haywood’s research interests are in the area of neurohumoral control of arterial pressure especially in experimental models of hypertension. He has focused on the action of circulating hormones and diet on neurotransmitter control of the paraventricular nucleus (PVN) of the hypothalamus in regulating the sympathetic nervous system and hypothalamic control of pituitary function and the genetics of the hypertensive phenotype, red blood cell sodium‐lithium countertransport activity, in the development of salt‐sensitive hypertension in the non‐human primate. He has served on editorial boards for the American Journal of Physiology, Hypertension, Physiological Genomics, and Clinical and Experimental Physiology and Pharmacology. In addition, he has been a member of NIH review panels including the NHLBI Program Project Committee.


Barbara Sanborn, Ph.D. Former Chair, Dept. of Biomedical Sciences Colorado State University Barbara Sanborn, Ph.D., from 2003‐2010 as Professor and Head of the Department of Biomedical Sciences in the College of Veterinary

Medicine and Biomedical Sciences at Colorado State University, Fort Collins, Colorado. She recently stepped down from that position to concentrate on her NIH‐funded research, which focuses on signal transduction and molecular mechanisms of hormone action. Her laboratory is currently studying crosstalk mechanisms between the cAMP and phospholipase C signaling pathways impacting myometrial contraction/relaxation and the role of specific ion channels in signal‐regulated calcium entry, endoplasmic reticulum calcium store refilling and calcium homeostasis. As Department Head, Dr. Sanborn administered a diverse department spanning the disciplines of anatomy, neuroscience and physiology. In addition to basic research programs and teaching responsibilities at several levels, the departmental mission includes an active clinical research, practice and outreach program. Although the department had merged in name in 2002, there were several obstacles to overcome before it could function effectively as a new entity. During her tenure as Head, Dr. Sanborn recruited 10 tenure‐track faculty members (all of whom have subsequently obtained extramural funding), appointed 11 special faculty members and spearheaded the initiation of a number of new programs. Prior to joining Colorado State, Dr. Sanborn was Professor and Vice‐Chair (2 yrs) in the Department of Biochemistry and Molecular Biology at the University of Texas Medical School at Houston. There she directed the NIH Training Program in Mammalian Reproduction for 17 years and served as Co‐Director of the Office of Women's Health and Director of Research. She has received NIH Research Career Development and Merit Awards. She has served on NIH study sections, editorial boards and on the Board of Directors and as President of the Society for the Study of Reproduction. She received the first Mentor of the Year Award at the University of Texas Medical School and has mentored undergraduate and graduate students, postdoctoral fellows and faculty members.


Thomas Westfall, Ph.D. Chair, Dept. of Pharmacology & Physiological Science Saint Louis University School of Medicine Thomas C. Westfall, Ph.D., is Professor and the William Beaumont Chair, Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine. Dr. Westfall received his Ph.D. in Pharmacology from West Virginia University School of Medicine and did postdoctoral work in the Department of Physiology, Karolinska Institute in Stockholm, Sweden. Dr. Westfall joined the Department of Pharmacology, University of Virginia School of Medicine in 1965, first as an Assistant Professor, then Associate Professor and finally full

Professor. Dr. Westfall joined the faculty in the Department of Pharmacology, Saint Louis University School of Medicine as Professor and Chair in 1979. He became Chair and William Beaumont Professor of the Department of Pharmacological and Physiological Science at Saint Louis University in 1990, a position he still occupies, as well as Director, Center of Excellence in Neuroscience, Saint Louis University. Dr. Westfall has served on numerous editorial boards and in a variety of service positions with academia and academic societies and federal review panels including: Treasurer and President, Association of Medical School Pharmacology Chairs; Chairman, Graduate Student Convocations Committee, American Society for Pharmacology and Experimental Therapeutics (ASPET); Chairman Nominating Committee, ASPET; Chairman Neuropharmacology Division, ASPET; President Catecholamine Club; Administrative Board of the Council of Academic Societies (CAS), Association of American Medical Colleges (AAMC); Executive Committee of the GREAT Group, AAMC; and membership on Experimental Cardiovascular Sciences Study Section, Pharmacological Sciences Review Committee and Parent Committee, Specialized Centers of Research in Hypertension, National Institutes of Health; and the Pharmacology Test Committee, National Board of Medical Examiners. Dr. Westfall has supervised the training of 24 Ph.D. students and 17 postdoctoral fellows. He is the Program Director of a training grant in Pharmacological Sciences from NIGMS that has been continuously funded since 1990. It was recently renewed for the 21st – 25th years. Dr. Westfall has given 56 invited presentations at National/International meetings and over 58 seminars at other institutions. He has received 9 teaching awards including The Golden Apple from graduating medical students at Saint Louis University School of Medicine. Dr. Westfall’s research involves coming to an understanding of the regulation of catecholamine neurotransmitter synthesis, storage and release from central and peripheral neurons; the role of cotransmission in physiological and pathophysiological conditions; and the interactions of the sympathetic and renin‐angiotensin system in the development and maintenance of hypertension. His research has been continuously funded from NIH and other agencies since 1965 and has been awarded 27 grants from NIH over the years. He has published over 200 peer reviewed papers and numerous review articles and text book chapters including Craig and Stitzel’s Modern Pharmacology and Goodman and Gilman’s The Pharmacological Basis for Therapeutics.


Mary Woolley, Ph.D. President Research!America

Mary Woolley is the president of Research!America, the nation's largest not‐for‐profit, membership supported grassroots public education and advocacy organization committed to making medical and health research a higher national priority. Under her leadership, Research!America has earned the attention and respect of elected and appointed officials, researchers in the public, private and academic sectors, media, and community leaders with its record of innovation in

advocacy for research. Research!America's reports and publications, websites, and constituent education initiatives have been honored by leading regional and international communications and advocacy organizations, including the Public Relations Society of America.

Woolley is an elected member of the Institute of Medicine and serves on its Governing Council. She is a Fellow of the American Association for the Advancement of Science (AAAS) and serves on the National Academies Board on Life Sciences. She is a founding member of the Board of Associates of the Whitehead Institute for Biomedical Research. Woolley has served as president of the Association of Independent Research Institutes (AIRI), as editor of the Journal of the Society of Research Administrators, as a reviewer for the National Institutes of Health and National Science Foundation, and as a consultant to several research organizations.

She has a 30‐year editorial and publication history on science advocacy and research related topics. Her op‐eds and letters to the editor are published in newspapers and magazines from coast to coast including The New York Times and Washington Post. She has been published in Science, Nature, Issues in Science and Technology, The New England Journal of Medicine, The Journal of the American Medical Association, The Scientist, Women's Health Magazine and others. She is a sought‐after speaker and is frequently interviewed by science, news and policy journalists and has received recognition by PBS as an "Unsung Heroine."

Woolley has an honorary doctoral degree from the Northeastern Ohio Universities Colleges of Medicine and Pharmacy. For her work on behalf of medical research, she has been honored as a Woman of Vision by the American Committee for the Weizmann Institute of Science and has received the American Hospital Association Silver Touchstone Award for Public Affairs Programming, the Columbia University College of Physicians and Surgeons Dean's Award for Distinguished Service, the Federation of American Societies for Experimental Biology Special Award for Science Advocacy, the Friends of the National Institute for Nursing Research Health Advocacy Award, the Awareness and Advocacy Award from the Clinical Research Forum, and the Friends of the National Library of Medicine Paul G. Rogers Public Service Award.

A native of Chicago, Woolley received a bachelor of science from Stanford University and a master of arts from San Francisco State University. In her early career, Woolley served as San Francisco project director for the then largest‐ever NIH‐funded clinical trial, the Multiple Risk Factor Intervention Trial (MRFIT). In 1981, she became administrator of the Medical Research Institute of San Francisco, and in 1986 was named the Institute's executive director and CEO. Woolley has served as president and CEO of Research!America since 1990.


Nader Abraham, Ph.D., Dr.H.C, F.A.H.A. Chair, Department of Physiology & Pharmacology University of Toledo Nadar Abraham is Professor and Chair of the Department of Physiology and Pharmacology at University of Toledo.

I focused my research on gene transfer and established an ideal condition for retrovirus transfer of the adenosine deaminase (ADA) gene. These findings, published in Stem Cell in 1993, showed that successful retrovirus gene transfer in hematopoietic stem cells within peripheral blood or cord blood can be efficient when mesenchymal stem cells , called adherent cell layers, are used. Our work on the use of stem cells in the treatment of diabetes was selected for presentations to The American Heart Association at the 2004 annual meeting. This led to the elucidation of the role of ROS in stem cell differentiation and the finding that bone marrow stem cells act as a metabolic organ (Am J Med, 1982). Our lab demonstrated that controlling ROS, via the induction of HO‐1, increased stem cell longevity, as measured in LTBMC, and showed that the proper mesenchymal stem cells or stromal microenvironment is essential for hematopoietic stem cell self‐renewal and differentiation. Our laboratory has also demonstrated that a proper stromal microenvironment is essential for promoting gene transfer into the CD34+ subset. Recently, we demonstrate that osteoblast differentiation is positively regulated by HO‐1 expression, which was associated with a reduction of ROS, thereby permitting the restoration of osteoblast markers, specifically, induction of OPG and osteocalcin, while HO‐1 expression negatively regulate adipocyte stem cell differentiation (ongoing research). Currently, our is now focusing on the use of stem cells to prevent hypertension and metabolic diseases in animal model and in human.


Frank Werblin, Ph.D. Department of Molecular & Cell Biology University of California, Berkley Frank Werblin is Professor Emeritus of Neurobiology in the Department of Molecular & Cell Biology at University of California at Berkeley. Our lab studies the neural circuitry in the retina that generates the representations of the visual world. The retina extracts about a dozen

different abstractions, formed at different strata within the retina, and transmitted separately along the optic nerve. We are determining the structural and functional circuit components of these abstractions. One dominant component of this circuitry is "crossover inhibition" found at every stage of visual processing At early stages of visual processing the world is divided into neurons that signal increases, and others that signal decreases in contrast at each point in visual space. Subsequent to that division in activity, these two signal paths begin to interact, and they inhibit each other at every single stage of visual processing from retina to visual cortex. This fascinating "crossover inhibition" takes many forms....feedback, feed forward, feed across. It also serves many important signal processing functions including common mode rejection, non‐linearity correction, drift compensation, and noise reduction. Our lab is studying the neural circuitry that mediates this crossover interaction in an attempt to learn the secrets embodied in this treasure trove of highly sophisticated biological technology.

The Association of Chairs of Departments of Physiology

Presents the 2010 Distinguished Service Award

To

John A. Williams, M.D., Ph.D. University of Michigan Medical School

An educator, administrator and investigator whose achievements have made a major impact on the field of pancreatic physiology, John A. Williams, M.D., Ph.D., is a professor of Molecular and Integrative Physiology and internal medicine in the University of Michigan Medical School. His research deals with the control of function of the exocrine pancreas. Dr. Williams received his medical and doctoral degree in Physiology & Biophysics from the University of Washington in 1968. He then completed a one‐year postdoctoral fellowship at the University of Utah and served as a Staff Associate in the Clinical Endocrinology Branch of the National Institute of Arthritis and Metabolic Diseases from 1969‐1971. He continued his postdoctoral training as a Helen Hay Whitney Foundation Fellow in the Department of Pharmacology at the University of Cambridge, United Kingdom and in 1973 joined the faculty at the University of California, San Francisco. At UCSF he rose to the position of Professor and Vice‐Chair of Physiology and Co‐Director of the Laboratory of Cell Biology at Mount Zion Hospital. He moved to the University of Michigan in1987 as Professor and Chair of the Department of Physiology, and he received a secondary appointment as Professor of Internal Medicine in 1988. He served as department chair for 21 years before stepping down from this leadership position in 2008 to focus on his research and teaching activities. During his tenure, the department grew and thrived as shown by its recent high ranking in the NRC Assessment of Research Doctorate Programs. Dr. Williams has been active in a number of scientific societies and served as President of the American Physiological Society and the American Pancreatic Association. He has received numerous awards, including the Gastrointestinal Section Prize of the American Physiological Society, the Ismar Boas Medal of the German Gastroenterological Association, and election as a

fellow of the American Association for the Advancement of Science. He also was honored by the American Pancreatic Association with a Lifetime Achievement Award, received the U‐M Distinguished Faculty Achievement Award in 2004, and a Distinguished Alumni award from Central Washington University in 2009. In 2009 he was named the first the Horace W. Davenport Collegiate Professor of Physiology at the U‐M. His distinguished career has included training more than 70 students and fellows, many of whom have gone on to obtain key positions at prestigious academic and research institutions. His work has led to over 270 peer‐reviewed papers in high‐quality journals and more than 75 reviews and book chapters. He served as Editor of the American Journal of Physiology: Gastrointestinal and Liver Physiology, Associate Editor for the Journal of Clinical Investigation, and Section Editor for the Annual Review of Physiology. Most recently, Dr. Williams was the founding editor of The Pancreapedia, an electronic knowledge base for the exocrine pancreas. He has served on two permanent NIH study sections and chaired one. He has been continuously funded by multiple grants since 1973 and one of his active grants has been awarded MERIT status by the National Institutes of Health. He also continues to serve as director of a Predoctoral Training Grant and as Associate Director of the Michigan Digestive Disease Center.

Previous ACDP Distinguished Service Awardees

2009 Phyllis M. Wise 2008 Irving H. Zucker 2007 William H. Dantzler 2006 Antonio Scarpa 2004 Daniel C. Tosteson 2003 L. Gabriel Navar 2002 Gabor Kaley 2001 Mordecai P. Blaustein 2000 Paul C. Johnson 1999 F. Norman Briggs 1998 Norman R. Alpert 1997 Carlton C. Hunt 1996 Arthur C. Guyton 1995 Aubrey E. Taylor 1994 Stanley G. Schultz

1993 Edward J. Masoro 1992 Gerhard H. Giebisch 1990 John T. Shepherd 1989 Walter C. Randall 1988 William F. Ganong 1987 Howard E. Morgan 1986 Horace Davenport 1985 Clifford Barger 1984 Harry Patton 1983 Ernst Knobil 1982 Hermann Rahn 1981 Robert Berliner 1980 George Sayers 1979 Ewald Seikurt 1978 William F. Ganong

BALLOT

Association of Chairs of Departments of Physiology 2010 Fall Retreat

Election of Officers For President Candidates: 1) 2) 3) Vote for 1: For the Office of Secretary-Treasurer Candidates: 1) 2) Vote for 1:

For the Office of Councillor Candidates: 1) 2) 3) 4) 5) 6) 7) Vote for 2: For the Office of CAS Representative Candidates: 1) 2) Vote for 1:

Association of Chairmen of Departments of Physiology

Revised 11/9/88

ASSOCIATION OF CHAIRMEN OF DEPARTMENTS OF PHYSIOLOGY

CONSTITUTION (As amended April 15, 1968)

ARTICLE I Section 1. The name of this organization shall be the Association of

Chairmen of Departments of Physiology

ARTICLE II

PURPOSES AND OBJECTIVES Section 1. The purpose and objective of this Association shall be to promote

discussion of problems of interest and concern to chairmen of departments of physiology.

ARTICLE III

MEMBERSHIP Section 1. The membership of the Association shall include the chairmen of

departments of physiology in accredited schools of medicine in the United States, Puerto Rico, Canada, and Mexico.

Section 2. Upon approval by the Council, membership will also be open to

individuals in other types of institutions who have similar responsibilities.

Section 3. Upon approval of the Council, in colleges of medicine lacking a

Department of Physiology, the administrative officer of an academic unit responsible for the discipline of physiology can be admitted to membership.

ARTICLE IV

OFFICERS AND COUNCIL Section 1. The officers of the Association shall consist of a President, a

President-Elect and a Secretary-Treasurer. The President and President-Elect shall serve for terms of one year. The Secretary-Treasurer shall serve for three years.

Section 2. The council shall consist of Officers, three Councilors and the past

President. Each Councilor shall ordinarily serve a term of three years. One new Councilor shall be elected each year.

ARTICLE V

MEETINGS Section 1. The time and place of the annual meeting and all called meetings

shall be determined by the Council. Section 2. Notice of time and place of all meetings shall be mailed to all

members at least thirty days prior to such meeting.

ARTICLE VI

QUORUM Section 1. A quorum for any regular or called meeting shall consist of 20% of

the members.

ARTICLE VII

CHARTER MEMBERS Section 1. All of those present at the first meeting, August 25, 1967, or who

qualify under Article III, Section 1 are automatically charter members, unless they decline.

ARTICLE VIII

AMENDMENTS Section 1. Amendments to this Constitution may be effected by two-thirds of

the voting members at a regular or called meeting provided that such an amendment has been submitted in writing to all members at least thirty days prior to such meeting.

ASSOCIATION OF CHAIRS OF DEPARTMENTS OF PHYSIOLOGY, INC.

BY-LAWS

ARTICLE I

Office

SECTION 1. Principal Office. The principal office of the Corporation shall be at the American Physiological Society, 9650 Rockville Pike, Bethesda, MD 20814. SECTION 2. Other Offices. The Corporation may also have an office or offices in such other places as the business of the Corporation may require and the Board of Directors may from time to time appoint.

ARTICLE II Members SECTION 1. Applications for Membership. Membership shall include the chairs of Departments of Physiology in accredited schools of medicine in the United States, Puerto Rico, Canada and Mexico. Upon approval of the Board of Directors, membership will also be open to

a. individuals in other types of institutions who have similar responsibilities, and b. the administrative officer of an academic unit responsible for the discipline of

physiology in colleges of medicine lacking a department of physiology. Emeritus Membership status is granted to former chairs that have held membership in ACDP for a total of 5 or more years. Emeritus members are invited to attend the annual meeting. Emeritus members can neither vote on Association business nor hold office. SECTION 2. Procedure. Membership eligibility shall be automatic upon appointment to a chair of a Department of Physiology, notification of the Secretary/Treasurer by the new member and payment of dues by the member. SECTION 3. Dues. The Board of Directors shall determine the annual dues for the members. SECTION 4. Attendance. Attendance at meeting shall be limited to members or guests invited with the approval of the Board of Directors. SECTION 5. Annual Meeting. The annual meeting of the members of the Corporation shall be held on a day duly designated by the Board of Directors either within or without the United States if not a legal holiday, and if a legal holiday then the next succeeding day not a legal holiday, for the transaction of such corporate business as may come before the meeting.

SECTION 6. Special Meetings. Special meetings of the members may be called at any time for any purpose or purposes by the Chair of the Board, by the President, by the President-elect, or by a majority of the Board of Directors, and shall be called forthwith by the Chair of the Board, the President, the President-elect, the Secretary-Treasurer or any director of the Corporation upon the request in writing of a majority of all the members entitled to vote on the business to be transacted at such meeting. Such request shall state the purpose or purposes of the meeting. Business transacted at all special meetings of members shall be confined to the purpose or purposes stated in the notice of the meeting. SECTION 7. Place of Holding Meetings. All meetings of members shall be held within or without the United States at a place designated by the Board of Directors. SECTION 8. Notice of Meetings. Written notice of each meeting of the members shall be mailed, postage prepaid by the Secretary/Treasurer, or sent by e-mail over the Internet or similar electronic communications equipment by the Secretary/Treasurer, to each member of record entitled to vote thereat at his/her post office address or e-mail address, as it appears upon the books of the Corporation, at least thirty (30) days before the meeting. Each such notice shall state the place, day, and hour at which the meeting is to be held and, in the case of any special meeting, shall state briefly the purpose or purposes thereof. SECTION 9. Quorum. The presence in person or by proxy of twenty percent (20%) of the members of the Corporation shall constitute a quorum at all meetings of the members except as otherwise provided by law, by the Articles of Incorporation or by these By-Laws. If less than a quorum shall be in attendance at the time for which the meeting shall have been called, the meeting may be adjourned from time to time by a majority vote of the members present or represented, without any notice other than by announcement at the meeting, until a quorum shall attend. At any adjourned meeting at which a quorum shall attend, any business may be transacted which might have been transacted if the meeting had been held as originally called. SECTION 10. Conduct of Meetings. Meetings of members shall be presided over by the President or the Corporation or, if the President is not present, by the President-elect, or, if none of said officers is present, by a chair to be elected at the meeting. The Secretary/Treasurer of the Corporation shall act as secretary of such meetings, in the absence of the Secretary-Treasurer the presiding officer may appoint a person to act as Secretary of the meeting. SECTION 11. Voting. At all meetings of members, every member entitled to vote thereat shall have one (1) vote. Such vote may be either in person or by proxy appointed by an instrument in writing subscribed by such member or the member’s duly authorized attorney, bearing a date not more than three (3) months prior to said meeting, unless said instrument provides for a longer period. Such proxy shall be dated, but need not be sealed, witnessed or acknowledged. All elections shall be held and all questions shall be decided by a majority of the votes cast at a duly constituted meeting, except as otherwise provided by law, in the Certificate of Incorporation or by these By-Laws. If the chair of the meeting shall so determine, a vote by ballot may be taken upon any election or matter, and the vote shall be so taken upon the request of ten percent (10%) or more of all the members entitled to vote on such election or matter. In either of such events,

the proxies and ballots shall be received and be taken in charge and all questions touching the qualification of voters and the validity of proxies and the acceptance or rejection of votes, shall be decided by members appointed by the chair of the said meeting.

ARTICLE III Board of Directors

SECTION I. General Powers. The property and business of the Corporation shall be managed under the direction of the Board of Directors of the Corporation. The Board shall be the policy making and administrative body of the corporation during the interval between the regular annual meetings and shall be empowered to enter into contracts and to authorize such expenditures as may be necessary to carry on the affairs of the Corporation. SECTION 2. Number and Term of Office. The number of Directors shall be either (8) or such other number, but not less than three (3) nor more than nine (9), as may be designated from time to time by resolution of a majority of the entire board of Directors. Directors shall be members of the Corporation. SECTION 3. Filling of Vacancies. In the case of any vacancy in the Board of Directors through death, resignation, disqualification, removal, or other cause, the office shall be left vacant unless filled by a vote of the members at a special meeting. SECTION 4. Place of Meeting. The Board of Directors may hold their meetings and have one or more offices, and keep the books of the Corporation, either within or outside the State of Maryland, at such place or places as they may from time to time determine by resolution or by, written consent of all the directors. The Board of Directors may hold their meetings by conference telephone, e-mail over the Internet or other similar electronic communications equipment if everyone can hear everyone else in accordance with the provisions of the General Corporation Law of the State of Maryland. SECTION 5. Regular Meetings. Regular meetings of the Board of Directors may be held without notice at such time and place as shall from time to time be determined by resolution of the Board, provided that written notice of each meeting of the Board of Directors shall be mailed, postage prepaid by the Secretary or sent by e-mail over the Internet or similar electronic communications equipment by the Secretary, to each member of record entitled to vote thereat at his/her post office address or e-mail address, as it appears upon the books of the Corporation, at least ten (10) days before the meeting. The annual meeting of the Board of Directors shall be held immediately following the annual meeting of members. Any business may be transacted at any regular meeting of the Board. SECTION 6. Special Meetings. Special meetings of the Board of Directors shall be held whenever called by any member of the Board of Directors. The Secretary shall give notice of each special meeting of the Board of Directors, by mailing the same at least three (3) days prior to the meeting or by e-mailing over the Internet the same at least two (2) days before the

meeting, to each Director, but such notice may be waived by any Director. Unless otherwise indicated in the notice thereof, any and all business may be transacted at any special meetings. At any meeting at which every Director shall be present, even though without notice, any business may be transacted and any Director may in writing waive notice of the time, place and objectives of any special meeting. SECTION 7. Quorum. A majority of the whole number of Directors shall constitute a quorum for the transaction of business at all meetings of the Board of Directors, but, if at any meeting less than a quorum shall be present, a majority of those present may adjourn the meeting from time to time, and the act of a majority of the Directors present at any meeting at which there is a quorum shall be the act of the Board of Directors, except as may be specifically provided, by law, or by the Articles of Incorporation of by these By-Laws. SECTION 8. Required Vote. An affirmative vote of a majority of those present shall be necessary for the passage of any resolution. All proceedings at the meeting of the Board of Directors or of any committee appointed by the Board shall be governed by Roberts Rules of Order, Revised, except where otherwise provided in these By-Laws. SECTION 9. Compensation of Directors. Directors shall not receive any stated salary for their services as such, but each director shall be entitled to receive from the Corporation reimbursement of the expenses incurred by the Director attending any regular or special meeting of the Board, and, by resolution of the Board of Directors a fixed sum may also be allowed for attendance at each regular or special meeting of the Board and such reimbursement and compensation shall be payable whether or not a meeting is adjourned because of the absence of a quorum. Nothing herein contained shall be construed to preclude any Director from serving the Corporation in any other capacity, and receiving compensation there for. SECTION 10. Standing Committees. The Board of Directors shall:

a. Elect two members of the Corporation to represent the corporation at the Council of Academic Societies (“CAS”) of the Association of American Medical colleges (“AAMC”). The CAS representatives shall attend Board meetings and make periodic reports to the Board and to the members of the Corporation. The term of appointment shall be for four (4) years, renewable once.

b. Elect a member of the Board to serve a three year term as Director of Public Affairs. SECTION 11. Other Committees. The Board of Directors may, by resolution passed by a majority of the whole Board, designate one or more other committees, each committee to consist of two or more of the directors of the Corporation, which, to the extend provided in the resolution, shall have and may exercise the powers of the Board of Directors, and may authorize the seal of the Corporation to be affixed to all papers which may require it. Such committee or committees shall have such names as may be determined from time to time by resolution adopted by the Board of Directors. SECTION 12. The Board of Directors shall allow Chairs in good standing to designate a member of the faculty of his or her Department to attend annual meetings in their absence as a

non-voting representative of the Department. Non-voting representatives shall not count toward the number of members needed to constitute a quorum. ARTICLE IV Officers SECTION 1. Election, Tenure and Compensation. The officers of the Corporation shall be a President, a President-elect, and a Secretary/Treasurer, and also such other officers including a Chair of the Board as the Board of Directors from time to time may consider necessary for the proper conduct of the business of the Corporation. The President and President-elect shall be elected annually by the members at the annual meeting of the members. The Secretary/Treasurer shall be elected every three years by the members at the annual meeting of members. All officers of the Corporation shall be directors. The Secretary and Treasurer offices may be held by the same person, but no officer shall execute, acknowledge or verify any instrument in more than one capacity if such instrument is required by law or by these By-Laws to be executed, acknowledged or verified by any two or more officers. The procedures for nominating and balloting will be determined at the time of the meeting of members. A majority of the members voting at a duly authorized meeting shall be necessary to elect the nominees. In the event that any office other than an office required by law, shall not be filled by the members, or, once filled, subsequently becomes vacant, then such office and all references thereto in these By-Laws shall be deemed inoperative unless and until such office is filled in accordance with the provisions of these By-Laws. All officers and agents of the Corporation shall be subject to removal at any time by the affirmative vote of a majority of the members voting at a duly authorized meeting of members, and any officers, agents, and employees, shall hold office at the discretion of the members. SECTION 2. Powers and Duties of the Chair of the Board. The Chair of the Board shall preside at all meetings of the Board of Directors unless the Board of Directors shall by a majority vote of a quorum thereof elect a chair other than the Chair of the Board to preside at meetings of the Board of Directors. The Chair of the Board may sign and execute all authorized bonds, contracts, or other obligations in the name of the Corporation, and he/she shall be ex-officio a member of all standing committees. SECTION 3. Powers and Duties of the President. The President shall be the chief executive officer of the Corporation and shall have general charge and control of all its business affairs and properties. The President shall preside at all meetings of the members. The President may sign and execute all authorized bonds, contracts or other obligations in the name of the Corporation. The President shall have signature power to sign checks under his/her signature in amounts below $1,000. The President shall have the general powers and

duties of supervision and management usually vested in the office of president of a corporation. The President shall be ex-officio a member of all the standing committees. The President shall do and perform such other duties as may, from time to time, be assigned to him/her by the Board of Directors. In the event that the Board of Directors does not take affirmative action to fill the office of Chair of the Board, the President shall assume and perform all powers and duties given to the Chair of the Board by these By-Laws. SECTION 4. Powers and Duties of the President-elect. The Board of Directors shall appoint a President-elect and the Board of Directors may appoint a Vice President. The President-elect (unless otherwise provided by resolution of the Board of Directors) may sign and execute all authorized bonds, contracts, or other obligations in the name of the Corporation. The President-elect shall have such other powers and shall perform such other duties as may be assigned to him/her by the Board of Directors or by the President. In case of the absence or disability of the President, the duties of that office shall be performed by the President-elect, and the taking of any action by the President-elect in place of the President shall be conclusive evidence of the absence or disability of the President. SECTION 5. Secretary/Treasurer.

a. The Secretary shall handle all voting matters, whether at actual meetings, telephonic meetings or meetings held on the Internet or other electronic media; he/she shall give, or cause to be given, notice of all meetings of members and directors and all other notices required by law or by these By-Laws, and in case of his/her absence or refusal or neglect to do so, any such notice may be given by any person thereunto directed by the President, or by the directors or members upon whose written request the meeting is called as provided in these By-Laws. The Secretary shall record all proceedings of the meetings of the members and of the directors in books provided for that purpose, and shall perform such other duties as may be assigned to him/her by the directors or the President. The Secretary shall have custody of the seal of the Corporation and shall affix the same to all instruments requiring it, when authorized by the Board of Directors or the President, and attest the same. In general, the Secretary shall perform all the duties generally incident to the office of Secretary, subject to the control of the Board of Directors and the President.

b. Treasurer. The Treasurer shall have custody of all the funds and securities of the Corporation, and he/she shall keep full and accurate account of receipts and disbursements in books belonging to the Corporation. The Treasurer shall deposit all moneys and other valuables in the name and to the credit of the Corporation in such depository or depositories as may be designated by the Board of Directors. The Treasurer shall have the power to sign checks under his/her signature in amounts up to $1,000. All checks for amounts over $1,000 shall require the signatures of two officers.

The Treasurer shall disburse the funds of the Corporation as may be ordered by the Board

of Directors, taking proper vouchers for such disbursements. He/she shall render to the President and the Board of Directors, whenever either of them so requests, an account of all his/her transactions as Treasurer and of the financial condition of the Corporation.

The Treasurer shall give the Corporation a bond, if required by the Board of Directors, in a sum, and with one or more sureties, satisfactory to the Board of Directors, for the faithful performance of the duties of his/her office and for the restoration to the Corporation in case of his/her death, resignation, retirement, or removal from office of all books, papers, vouchers, moneys, and other properties of whatever kind in his possession or under his control belonging to the Corporation.

The Treasurer shall perform all the duties generally incident to the office of the Treasurer,

subject to the control of the Board of Directors and the President.

SECTION 6. Assistant Secretary. The Board of Directors may appoint an Assistant Secretary or more than one Assistant Secretary. Each Assistant Secretary shall (except as otherwise provided by resolution of the Board of Directors) have power to perform all duties of the Secretary in the absence or disability of the Secretary and shall have such other powers and shall perform such other duties as may be assigned to him/her by the Board of Directors or the President. In case of the absence or disability of the Secretary, the duties of the office shall be performed by any such Assistant Secretary, and the taking of any action by any such Assistant Secretary in place of the Secretary shall be conclusive evidence of the absence or disability of the Secretary. SECTION 7. Assistant Treasurer. The Board of Directors may appoint an Assistant Treasurer or more than one Assistant Treasurer. Each Assistant Treasurer shall (except as otherwise provided by resolution of the Board of Directors) have power to perform all duties of the Treasurer in the absence or disability of the Treasurer and shall have such other powers and shall perform such other duties as may be assigned to him/her by the Board of Directors or the President. In case of the absence or disability of the Treasurer, the duties of the office shall be performed by any Assistant Treasurer, and the taking of any action by any such Assistant Treasurer in place of the Treasurer shall be conclusive evidence of the absence or disability of the Treasurer. ARTICLE V Corporate Seal SECTION 1. Seal. In the event that the President shall direct the Secretary to obtain a corporate seal, the corporate seal shall be circular in form and shall have inscribed thereon the name of the Corporation, the year of its organization and the word “Maryland”. Duplicate copies of the corporate seal may be provided for use in the different offices of the Corporation but each copy thereof shall be in the custody of the Secretary of the Corporation or of an Assistant Secretary of the Corporation nominated by the Secretary.

ARTICLE VI Bank Accounts and Loans SECTION 1. Bank Accounts. Such officers or agents of the Corporation as from time to time shall be designated by the Board of Directors shall have authority to deposit any funds of the Corporation in such banks or trust companies as shall from time to time be designated by the Board of Directors, and such officers or agents as from time to time shall be authorized by the Board of Directors may withdraw any or all of the funds of the Corporation so deposited in any such bank or trust company, upon checks, drafts, or other instruments or orders for the payment of money, drawn against the account or in the name or behalf of this Corporation, and made or signed by such officers or agents; and each bank or trust company with which funds of the Corporation are so deposited is authorized to accept, honor, cash and pay, without limit as to amount, all checks, drafts or other instruments or orders for the payment of money, when drawn, made or signed by officers or agents so designated by the Board of Directors until written notice of the revocation of the authority of such officers or agents by the Board of Directors shall have been received by such bank or trust company. There shall from time to time be certified to the banks or trust companies in which funds of the Corporation are deposited, the signature of the officers or agents of the Corporation so authorized to draw against the same. In the event that the Board of Directors shall fail to designate the persons by whom checks, drafts and other instruments or orders for the payment of money shall be signed, as hereinabove provided in this Section, all of such checks, drafts and other instruments or orders for the payment of money shall be signed by the President or President-elect and countersigned by the Secretary/Treasurer or an Assistant Secretary or an Assistant Treasurer of the Corporation. SECTION 2. Loans. Such officers or agents of this Corporation as from time to time shall be designated by the Board of Directors shall have authority to effect loans, advances or other forms of credit at any time or times for the Corporation from such banks, trust companies, institutions, corporations, firms or persons as the Board of Directors, shall from time to time designate, and as security for the repayment of such loans, advances, or other forms of credit to assign, transfer, endorse and deliver, either originally or in addition or substitution, any or all stocks, bonds, rights and interests of any kind in or to stocks or bonds, certificates of such rights or interests, deposits, accounts, documents covering merchandise, deposits and accounts receivable and other commercial paper and evidences of debt at any time held by the Corporation, and for such loans, advances or other forms of credit to make, execute and deliver one or more notes, acceptances or written obligations of the Corporation on such terms, and with such provisions as to the security or sale or disposition thereof as such officers or agents shall deem proper; and also to sell to, or discount or rediscount with, such banks, trust companies, institutions, corporations, firms or persons any and all commercial paper, bills receivable, acceptances and other instruments and evidences of debt at any time held by the Corporation, and to that end to endorse, transfer and deliver the same. There shall from time to time be certified to each bank, trust company, institution, corporation, firm or person so designated the signatures of the officers or agents so authorized; and each such bank, trust company, institution, corporation, firm or person is authorized to reply upon such certification until written notice of the revocation by the Board of Directors of the authority of such officers or agents shall be delivered to such bank, trust company, institution, corporation, firm or person.

ARTICLE VII Reimbursements SECTION 1. Reimbursements. Any payments made to an officer or other employee of the Corporation, such as salary, commission, interest or rent, or entertainment expense incurred by him/her, which shall be disallowed in whole or in part as a deductible expense by the Internal Revenue Service, shall be reimbursed by such officer or other employee of the Corporation to the full extent of such disallowance. It shall be the duty of the Directors, as a Board, to enforce payment of each such amount disallowed. In lieu of payment by the officer or other employee, subject to the determination of the Board of Directors, proportionate amounts may be withheld from his/her future compensation payments until the amount owed to the Corporation has been recovered. ARTICLE VIII Miscellaneous Provisions SECTION 1. Fiscal Year. The fiscal year of the Corporation shall end on the last day of December. SECTION 2. Notices. Whenever, under the provisions of these By-Laws, notice is required to be given to any Director, officer or member it shall not be construed to mean personal notice, but such notice shall be given in writing, by email over the Internet, by mail, by depositing the same in a post office or letter box, in a postpaid sealed wrapper, addressed to each member officer or director at such address as appears on the books of the Corporation, or in default of any other address, to such director, officer or member at the general post office in the City of Rockville, Maryland, and such notice shall be deemed to be given at the time the same shall be thus mailed. Any member, Director or officer may waive any notice required to be given under these By-Laws. SECTION 3. Waiver, Consent. Any notice required to be given under these By-Laws or otherwise may be waived by the Director, officer or member to whom such notice is required to be given and the presence of any person at a meeting shall constitute waiver of notice thereof as to such person. Any action which may be taken at a meeting of the Directors, officers or members may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the Directors, officers or members entitled to vote with respect to the subject matter thereof. Such consent shall have the same force and effect as an unanimous vote of the Directors, officers or members, as the case may be.

ARTICLE IX Amendments SECTION 1. Amendment of By-Laws. Any member can propose an amendment of the By-Laws by submitting the change to the President. If a majority of the Members adopt the amendment it shall be adopted provided that such amendment has been submitted in writing to all Members by mail at least thirty days prior to such meeting. Without prior notification, amendment of the By-Laws may be accomplished by the unanimous consent of the members voting at an annual or special meeting of the members. ARTICLE X Indemnification SECTION 1. Definitions. As used in this Article X, any word or words that are defined in Section 2-418 of the Corporations and Associations Article of the Annotated Code of Maryland, as amended from time to time, (the “Indemnification Section”) shall have the same meaning as provided in the Indemnification Section. SECTION 2. Indemnification of Directors and Officers. The Corporation shall indemnify and advance expenses to a Director or officer of the Corporation in connection with a proceeding to the fullest extent permitted by and in accordance with the Indemnification Section. SECTION 3. Indemnification of Employees and Agents. With respect to an employee or agent, other than a Director or officer, of the Corporation, the Corporation may, as determined by the Board of Directors of the Corporation, indemnify and advance expenses to such employee or agent in connection with a proceeding to the extent permitted by and in accordance with the Indemnification Section.

Amended 12/2006

Association of Chairs of Departments of Physiology · Association of Chairs of Departments of...

Documents

Transcript of Association of Chairs of Departments of Physiology · Association of Chairs of Departments of...